COMPARISON OF RENAL DYSFUNCTION IN SYSTOLIC HEART FAILURE PATIENTS TREATED WITH SACUBITRIL-VALSARTAN OR ACE INHIBITOR/ANGIOTENSIN RECEPTOR BLOCKER

被引：1
|
作者：
Tan, Nicholas [1 ]
Deng, Yihong [1 ]
Yao, Xiaoxi [1 ]
Sangaralingham, LIndsey [1 ]
Shah, Nilay [1 ]
Rule, Andrew [1 ]
Burnett, John [1 ]
Dunlay, Shannon [1 ]
Sangaralingham, Jeson [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1415-77
引用
收藏
页码：1023 / 1023
页数：1
相关论文
共 50 条
  • [31] Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
    Fala, Loretta
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (06):
  • [32] Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM
    Lillyblad, Matthew P.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (11) : 1237 - 1251
  • [33] USE OF VALSARTAN-SACUBITRIL IN ELIGIBLE SYSTOLIC HEART FAILURE PATIENTS
    Dhamija, Yashu
    Kaelber, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 765 - 765
  • [34] Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis
    Dewi, Kadek Intan Murti
    Pintaningrum, Yusra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [35] Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients
    Rascon Sabido, R. Rafael
    Rodriguez Cesar, Santos
    Escobar Gerardo, Baca
    Padron Lucio, San Juan
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 193 - 193
  • [36] The Efficacy of Sacubitril-Valsartan in Congestive Heart Failure Patients Who Also Have End Stage Renal Disease
    Kazi, Usman
    AL-Nasseri, Abraheim
    Mirabella, Steven
    Nerella, Nishant
    Pasupuleti, Suman
    CIRCULATION, 2024, 150
  • [37] Should All Heart Failure Patients Be Treated With Sacubitril/Valsartan?
    Blankfield, Robert P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (01) : 98 - 98
  • [38] Renal protective effect of sacubitril/valsartan in patients with heart failure
    Hui-Ling Hsieh
    Chun-You Chen
    Cheng-Hsien Chen
    Shih-Chang Hsu
    Wen-Cheng Huang
    Yuh-Mou Sue
    Feng-Yen Lin
    Chun-Ming Shih
    Yue-Cune Chang
    Po-Hsun Huang
    Chung-Te Liu
    Scientific Reports, 11
  • [39] Angiotensin II Receptor Blocker And Neprilysin Inhibitor Sacubitril/valsartan Attenuates Experimental Pulmonary Hypertension
    Clements, Richard T.
    Vang, Alexander
    Kue, Nouaying R.
    Mancini, Thomas
    Morrison, Alan R.
    McCullough, Danielle J.
    Mallem, Krishna
    Choudhary, Gaurav
    CIRCULATION, 2019, 140
  • [40] Renal protective effect of sacubitril/valsartan in patients with heart failure
    Hsieh, Hui-Ling
    Chen, Chun-You
    Chen, Cheng-Hsien
    Hsu, Shih-Chang
    Huang, Wen-Cheng
    Sue, Yuh-Mou
    Lin, Feng-Yen
    Shih, Chun-Ming
    Chang, Yue-Cune
    Huang, Po-Hsun
    Chung-Te Liu
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345